Standout Papers
- Report of the Committee on Hodgkin's Disease Staging Classification. (1971)
Citation Impact
Citing Papers
Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease
2007
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
1997
Restaging laparotomy in the management of the non‐Hodgkin lymphomas
1982
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
1991
A single-centre experience of post-renal transplant lymphoproliferative disorder
2003
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients
1998
A view on drug resistance in cancer
2019 StandoutNature
Sjögren's syndrome
2005 Standout
Cd30+ cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma
2003
CHOP versus MACOP-B in aggressive lymphoma - a Nordic Lymphoma Group randomised trial
1999
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type
1999
Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma
2002
Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma
2004
Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma
2004
Phenotypic conversion of T lymphoblastic lymphoma to acute biphenotypic leukemia composed of lymphoblasts and myeloblasts. Molecular genetic evidence of the same clonal origin.
1988 StandoutNobel
Expression of nm23‐H1 is associated with poor prognosis in peripheral T‐cell lymphoma
2003
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
1994
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphoma
2003
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Treatment of Non-Hodgkin's Lymphoma
1993
T‐cell‐rich B‐cell lymphoma presenting in skin
1996
Celiac Disease
2007 Standout
Epigenetics in Cancer
2008 Standout
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
1995
LONG-TERM SURVIVORS OF CHILDHOOD CANCER
1997
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Malignant lymphoma in primary Sj�gren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sj�gren's syndrome
1999
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
Immunity, Inflammation, and Cancer
2010 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Infectious agents and lymphoma development: molecular and clinical aspects
2009
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
1994
Helicobacter pyloriInfection
2002 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards
1987 StandoutNobel
Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences in AIDS-Related Body-Cavity–Based Lymphomas
1995 Standout
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.
1989
Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.
1995
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
1998
Rearrangement of the bcl-6 Gene as a Prognostic Marker in Diffuse Large-Cell Lymphoma
1994
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
1999
Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders
1992
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1
2004
Preservation of Fertility in Patients with Cancer
2009 Standout
Anemia of Chronic Disease
2005 Standout
Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease
1998
Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma
1993
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
1975
Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma
1979
Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
2002
Wall stress and patterns of hypertrophy in the human left ventricle.
1975 Standout
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor
1995
Hematologic Neoplasia in Patients Treated for Hodgkin's Disease
1977
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
1986 StandoutScience
Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin‧s lymphoma
1993
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
1990 Standout
Prognostic effect of weight loss prior tochemotherapy in cancer patients
1980 Standout
Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.
1996
Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)
1978
Revised Response Criteria for Malignant Lymphoma
2007 Standout
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
2001
Female Reproductive Potential after Treatment for Hodgkin's Disease
1981 Standout
Cancer of the larynx: A new staging system and a re-appraisal of prognosis and treatment
1977
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases.
2003
Burkitt's Lymphoma
1981
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
2001 Standout
The Will Rogers Phenomenon
1985 Standout
Pancytopenia and Leukemia in Hodgkin’s Disease: Report of Three Cases
1973 StandoutNobel
Architecture of the Human Lung
1962 StandoutScience
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Serum Migration-Inhibitory Activity in Patients with Lymphoproliferative Diseases
1974 StandoutNobel
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
1998
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Frequencies and patterns of bone marrow involvement in non‐hodgkin lymphomas: Observations on the value of bilateral biopsies
1977
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Heart failure from the point of view of quantitative anatomy∗
1960
A case control study on immunity to two epstein‐barr virus‐associated antigens, and to herpes simplex virus and adenovirus in a population‐based group of patients with hodgkin's disease in denmark, 1971–73
1977
Viruses in Human Cancers
1991 StandoutScienceNobel
“sternberg‐reed” giant cells of hodgkin's disease: Cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages
1977
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Malignant lymphoma, lymphoblastic
1976
Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma
2001
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
1977 Standout
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67Gallium Scan in 50 Patients
1999
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.
1983 StandoutNobel
Results of total body irradiation in the treatment of advanced non-Hodgkin's lymphomas
1979
Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease.
1971
Non-hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types.Results of sequential staging procedures, response to therapy, and survival of 100 patients
1978
The Anthracycline Antineoplastic Drugs
1981 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Pseudolymphoma in Renal Allograft Recipients
1978
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies
2000
Curability of Advanced Hodgkin's Disease with Chemotherapy
1980
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single Center
2000
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Malignant Lymphoma
1973
Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.
1997
Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy
1977
Works of K. Musshoff being referenced
Prognostic and therapeutic implications of staging in extranodal Hodgkin's disease.
1971
Über physiologische und pathophysiologische Grundlagen der Röntgendiagnostik des Herzens1. I. Mitteilung: Anpassungsvorgänge des gesunden Herzens an physiologische Belastungen
1955
Unspezifische Mesenchymreaktionen und Parenchymsch�den der Leber bei Patienten mit Morbus Hodgkin
1970
Report of the Committee on Hodgkin's Disease Staging Classification.
1971 Standout
Klinische Stadieneinteilung der Nicht-Hodgkin lymphome
1977
Über physiologische und pathophysiologische Grundlagen der Röntgendiagnostik des Herzens
1955
[Clinical staging classification of non-Hodgkin's lymphomas (author's transl)].
1977
Long-term side effects in irradiated patients with Hodgkin's disease
1977